Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial.
Tools
Nisbet-Brown, Eric, Olivieri, Nancy F, Giardina, Patricia J, Grady, Robert W, Neufeld, Ellis J, Sechaud, Romain, Krebs-Brown, Axel, Anderson, Judith, Alberti, Daniele Maria, Sizer, Kurt and Nathan, David G (2003) Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial. Lancet, 361 (9369). pp. 1597-1602. ISSN 0140-6736
Official URL: http://www.sciencedirect.com/science/article/pii/S...
Abstract
Transfusional iron overload is a potentially fatal complication of the treatment of thalassaemia. We aimed to investigate short-term efficacy, pharmacokinetic/pharma- codynamic (PK/PD) relations, and safety of ICL670, a novel, tridentate, orally active iron chelator.
Item Type: | Article |
---|---|
Related URLs: | |
Related URLs: | |
Date Deposited: | 28 Jan 2012 00:45 |
Last Modified: | 01 Feb 2013 00:46 |
URI: | https://oak.novartis.com/id/eprint/5608 |